Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Chronic heart failure e-posters
ESC 365 is supported by
